Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Thymoglobulin and Delayed CNI for Renal Protection in Liver Transplant
NCT00970073Phase 2Completed
- Sponsor
- Cleveland Clinic
- Start
- Aug 2009
- Primary completion
- Jun 2015
- Modality
- Engineered Antibody Formats, Antibody Conjugates, Monoclonal Antibodies
- Countries
- 1
01
Overview
Phase 2, randomised, open-label trial of antithymocyte globulin in liver transplantation, sponsored by Cleveland Clinic. Started Aug 2009; status: completed.
02
Drugs
antithymocyte globulin
03
Conditions
liver transplantation
Beyond the preview
Go deeper on NCT00970073.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00970073.